There has been an alarming rise in patients presenting with atypical recalcitrant types of dermatophytosis in the past few years, with frequent relapses shortly after finishing the treatment course. The emergence of widespread resistance to antifungals with increasing clinical failure rates warrants the search for a novel and antifungal strategy that brings about rapid clinical and mycological cure in cases of recalcitrant tinea.